Articles
7,378 Articles
Psychedelic Invest
/
Sep 18, 2024
Awakn Life Sciences Announces Upsizing and Closing of Tranche of Private Placement Financing
Toronto, Ontario–(Newsfile Corp. – September 18, 2024) – Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn” or the “Company”) a clinical-stage biotechnology company developing therapeutics for substance use and mental health disorders, with a near-term focus on...
Psychedelic Invest
/
Sep 18, 2024
Revive Therapeutics Announces Strategic Focus on Bucillamine for Infectious Diseases and Medical Countermeasures
TORONTO, Sept. 18, 2024 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for infectious diseases and medical countermeasures,...
Psychedelic Invest
/
Sep 18, 2024
Psyence Group’s NASDAQ-Listed Associate, Psyence Biomed Issues Shareholder Update Recapping Recent Progress and Previewing Key Upcoming Data Milestones
NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) — Psyence Group Inc (“Psyence Group“) (CSE: PSYG), a life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing, is pleased to announce that its NASDAQ-listed associate, Psyence Biomedical Ltd....
Psychedelics Today
/
Sep 17, 2024
Finding Your Soul’s Purpose: Harnessing Psychedelic Insights for Professional Growth
Psychedelic experiences can be a key drivers toward finding your soul’s purpose. But how can the insights learned lead to professional growth or a completely new career? In this episode, Kyle interviews Beth Weinstein: spiritual business coach, host of the “Medicine For These Times” podcast,...
DoubleBlind Mag
/
Sep 17, 2024
Cadillac Unveils Electric Vehicle with Reishi Mushroom Leather Interior
A biotech company called MycoWorks just crafted “leather” for parts of Cadillac’s electric car’s interior using mycelium from Reishi mushrooms. The “Sollei” is still a concept car, but according to Design Bloom, the mycelium biomaterial appears as accents inside the vehicle and has been...
DoubleBlind Mag
/
Sep 16, 2024
Here Are the Trippiest Video Games for PC
Renowned video game designer Sid Meier once said, “A game is a series of interesting choices.” On that note, choosing a psychedelic-friendly video game – to either enhance a trip or to simply emulate one – is easily the most interesting choice you can make. Not all video games are created...
Psychedelic Invest
/
Sep 16, 2024
Psyence Biomedical Ltd. Announces Receipt of Staff Delisting Determination from Nasdaq
NEW YORK, Sept. 13, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM) announced that on September 12, 2024, the Company received a staff determination letter (the “Determination Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market...
Psychedelic Invest
/
Sep 16, 2024
Psyence Biomed Issues Shareholder Update Recapping Recent Progress and Previewing Key Upcoming Data Milestones
NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today issued the following update to shareholders: Dear shareholders: It has been an eventful and productive few months since my last letter in March, and I wanted to take...
DoubleBlind Mag
/
Sep 13, 2024
Luxury Mushroom Retreats for CEOs Show Psychedelics Can Fuel Capitalism
Spiritual evangelism runs through psychedelic culture, particularly in the ’60s and ’70s when pioneers like Tim Leary, Ken Kesey, and Owsley Stanley embarked on quests to dose the world. These leading figures believed that turning people on to psychedelics would bring about a revolution in human...
LSD
Psychedelics
Psilocybin Alpha
/
Sep 13, 2024
Real-World Data Reveals Variability in Access to, and Use of, Spravato
Janssen’s esketamine nasal spray product, Spravato, was first approved around half a decade ago in 2019, initially indicated for use alongside an oral antidepressant for treatment-resistant depression (TRD). The next year, FDA allowed Janssen to add major depressive disorder (MDD) with acute...
Psychedelics Today
/
Sep 13, 2024
How to Create Your Own Psychedelic Integration Circle
As more people have experiences with non-ordinary states, integration becomes more important than ever. But if there isn’t one in your area, how can you create your own psychedelic integration circle? In this episode, David interviews Daniel Shankin: psychedelic integration coach, Vital...
Psychedelic Invest
/
Sep 12, 2024
Psyence Biomed Announces the Signing of a Conditional Binding Term Sheet for the Acquisition of Psilocybin-Based Drug Developer Clairvoyant
NEW YORK, Sept. 06, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced that the Company has entered into a conditional binding term sheet with privately-held Clairvoyant Therapeutics Inc (“Clairvoyant”), a clinical-stage...
Psychedelic Invest
/
Sep 12, 2024
Bright Minds Biosciences Initiates the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy
NEW YORK, Sept. 12, 2024 /CNW/ – Bright Minds Biosciences Inc. (NASDAQ: DRUG), a biotechnology company focused on developing novel therapies for neurological and neuropsychiatric disorders, today announced the initiation of the BREAKTHROUGH Study, an open-label Phase 2 clinical trial evaluating...
Psychedelic Invest
/
Sep 12, 2024
Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment
Vancouver, Canada, Sept. 06, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health...
MDMA
DoubleBlind Mag
/
Sep 12, 2024
What Does the Death Card Mean in Tarot?
Tarot cards are for fun at their core. They evolved from games and are best interpreted in creative, fluid ways. Many people take them too seriously, which can lead to unnecessary worries. And perhaps the card that scares people the most is the death card. After all, what is more frightening than...
Psychedelic Invest
/
Sep 12, 2024
Clearmind Medicine and Yissum File International Patent Application for Revolutionary Psychedelic Compounds for PTSD Treatment
Vancouver, Canada, Sept. 12, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health...
Psychedelic Invest
/
Sep 12, 2024
Braxia Announces Annual General and Special Meeting
Toronto, Ontario–(Newsfile Corp. – September 10, 2024) – Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960) (“Braxia Scientific”, or the “Company”) announced today that an annual general and special meeting (the “Meeting”) of the common shareholders will be held in...
Psychedelic Invest
/
Sep 12, 2024
Psyence Biomed Announces Initiation of First Trial Site in Australia for its Phase IIb Study of Nature Derived Psilocybin as a Potential Treatment for Adjustment Disorder in Palliative Care
NEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”), a developer of naturally derived psilocybin-based therapeutics, today announced that the first site initiation visit has been successfully completed at the first...
Psilocybin
Psychedelic Invest
/
Sep 12, 2024
PharmAla to supply Johns Hopkins Medicine for Clinical Trial
TORONTO, Sept. 11, 2024 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is proud...
MDMA
DoubleBlind Mag
/
Sep 12, 2024
Court Rules Psychedelic Mushroom Dispensary Can Remain Open in Vancouver
When an inspector from the City of Vancouver visited the Coca Leaf Café in February 2022, located near the downtown area of the city, he reported that more than 90 percent of the business was related to the sale of magic mushrooms. The rest of the business was likely judged for its sale of other...
Psilocybin
Psychedelics Today
/
Sep 12, 2024
The ‘Nada Effect’: Why Psychedelics Don’t Work for Everyone
Despite the dose, the substance, or a carefully tuned set and setting, seemingly, psychedelics don’t always work for everyone. This frustrating phenomenon known as the “nada effect” sometimes shows up, and leaves individuals without the psychedelic trip they expected. But why does this happen?...
Psychedelics
Zen Habits
/
Sep 12, 2024
Transforming Our Complaints into Something Generative
By Leo Babauta Something that has long been a struggle for me is when people complain a lot — I really don’t love the negative energy, and I tend to turn away from people who are complaining. So I’ve been examining this in recent years … and I’ve been learning a lot about myself. The first...
Psychedelic Invest
/
Sep 12, 2024
Revitalist Announces Strategic Partnership with Sama Therapeutics to Advance Digital Human AI Agents for Precision Mental Health
Vancouver, British Columbia–(Newsfile Corp. – September 9, 2024) – Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO), a leader in comprehensive mental health and wellness care, is excited to announce a research and patient care partnership with Sama Therapeutics for...
Psychedelics - Green Market Report
/
Sep 11, 2024
Psilocybin CEO arrested at airport fleeing stock fraud charges
The U.S. Department of Justice announced that the chief executive officer of psilocybin company Minerco Inc. (OTC: MINE), Julius Jenge was arrested on Aug. 22 at Ronald Reagan Washington National Airport, where he was booked on a one-way flight to Tanzania. The former CEO was fleeing a Securities...
DoubleBlind Mag
/
Sep 11, 2024
MAPS Wants Voters to Legalize MDMA Therapy If the FDA Won’t
On Friday, September 6, MAPS assembled a panel of experts during a press conference to discuss what comes after the recent FDA denial of MDMA-assisted therapy. The press conference followed on the heels of the FDA and Reagan-Udall Foundation’s public meeting on PTSD earlier that day, which...
MDMA
Psychedelics
DoubleBlind Mag
/
Sep 11, 2024
Penny Vieregge’s Lives Every Day in a State of Psychedelic Synesthesia
“I’m the wrong one, in a way, for a psychedelic magazine because I didn’t do psychedelics,” Penny Vieregge tells me, sitting under a flowering plum tree hung with crystals, her hands wrapped around a silver goblet. Except for that one time she tried LSD, of course, and the six-ish months she...
Psychedelics - Green Market Report
/
Sep 11, 2024
FDA sidesteps MDMA controversy at PTSD meeting, but public pushes back
A recent U.S. Food and Drug Administration meeting on post-traumatic stress disorder treatments has reignited, within more official channels, the debate over the agency’s decision last month to delay approval of privately-owned Lykos Therapeutics‘ MDMA-assisted therapy. The Sept. 6 hybrid...
MDMA
Psychedelic Invest
/
Sep 10, 2024
Silo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSD
SARASOTA, FL, Sept. 10, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today...
DoubleBlind Mag
/
Sep 10, 2024
Combining Ozempic with Psychedelic Compound May Treat Diabetes, Research Suggests
Millions of individuals grappling with type 1 or type 2 diabetes rely on insulin injections or medications to manage their blood sugar levels. This condition arises from the destruction of the pancreas’s limited beta cells — the sole source of insulin in the body. But now researchers say there...
Ayahuasca
Psychedelics Today
/
Sep 10, 2024
Psychedelic Outlaws: Cluster Headaches, Citizen Science, and the Story of ClusterBusters
Cluster headaches are considered to be the most severe pain a person can experience. With scarce research and no funding, citizen-led science has taken over, and sufferers may have discovered the answer: psychedelics. In this episode, Joe interviews Joanna Kempner, Ph.D.: associate professor in the...
Psychedelics - Green Market Report
/
Sep 10, 2024
Reverse split for AdvisorShares Psychedelic ETF starts today
The one-for-ten reverse split for the AdvisorShares Psychedelics ETF starts with today’s trading. The split will not change the total value of a shareholder’s investment. That means every ten shares of the fund will be exchanged for one share. Furthermore, the total number of issued and...
MDMA
Psychedelics
Psychedelic Invest
/
Sep 10, 2024
Incannex Healthcare Announces Strategic Financing for up to $60 Million with Arena Investors
NEW YORK and MELBOURNE, Australia, Sept. 10, 2024 (GLOBE NEWSWIRE) — Incannex Healthcare Inc. (Nasdaq: IXHL), (the “Company” or “Incannex”), a clinical-stage biopharmaceutical company developing life-changing medicines for people with chronic diseases and significant unmet medical needs,...
DoubleBlind Mag
/
Sep 09, 2024
Biotech Firm Makes Trip-Free Psilocybin Drug to Treat Dementia
A psilocybin-based drug developed by the biotech company Psilera cleared a key milestone for human safety, the company announced last week. Psilocybin is an active ingredient in psychedelic, or “magic,” mushrooms, though this pharmaceutical version won’t make anyone trip. The drug, called...
Psilocybin
Psilocybin Alpha
/
Sep 09, 2024
Pα+ Psychedelic Bulletin #172: Lykos Scales Back IIT Program, CEO Steps Down; Psyence Scoops Up Clairvoyant for Peanuts; Mindstate’s Moxy Enters Phase I
In the wake of FDA’s rejection of Lykos Therapeutics’ MDMA-assisted therapy for PTSD new drug application (NDA), many individuals and organisations associated with the company are trying to make sense of their professional futures—not least the 75% of the company’s staff who were laid off...
DoubleBlind Mag
/
Sep 09, 2024
Lessons From Legal Weed Will Shape Colorado’s New Psychedelics Law
In a new podcast interview, Colorado’s top cannabis regulator looks back on the history of the state’s first-in-the-nation adult-use marijuana market, noting that she expects the lessons learned over the years will inform how her office approaches setting up Colorado’s new legal psychedelics...
Psilocybin
Cannabis
Psychedelics
Lucid News
/
Sep 06, 2024
Thomas Hartle Leaves A Legacy of Hope
A memorial service will be held on Friday, September 6, for Thomas Hartle, the mild-mannered computer professional who quietly changed the history of psychedelic medicine in Canada after receiving a diagnosis of metastatic colon cancer. His family has invited the public to join the memorial...
